At CD BioSciences, scientific collaboration and knowledge exchange are at the heart of our mission. Our participation in global events underscores our commitment to advancing research and development in the field of human herpesviruses (HHVs). Through active involvement in international conferences, industry symposia, academic workshops, and partnering meetings, we aim to connect with innovators, share our HHV-specific solutions, and stay at the forefront of virology and preclinical innovation.
Each year, we engage with a diverse scientific community across North America and Europe, contributing to discussions on antiviral drug discovery, vaccine platforms, and novel therapeutic approaches targeting alpha-, beta-, and gamma-herpesviruses. Whether presenting case studies, showcasing our platform capabilities, or networking with biopharma leaders, these events provide a vital opportunity to foster partnerships and accelerate translational impact.
Visitors are encouraged to explore our event calendar for upcoming opportunities to meet our expert team. From HHV-focused research summits to biotech partnering forums, CD BioSciences is proud to be an active participant in shaping the future of HHV-related therapeutic development.